Inflammation-Induced Tryptophan Breakdown is Related With Anemia, Fatigue, and Depression in Cancer

Abstract

Many patients with cancer suffer from anemia, depression, and an impaired quality of life (QoL). These patients often also show decreased plasma tryptophan levels and increased kynurenine concentrations in parallel with elevated concentrations of Th1 type immune activation marker neopterin. In the course of anti-tumor immune response, the pro-inflammatory cytokine interferon gamma (IFN-γ) induces both, the enzyme indoleamine 2,3-dioxygenase (IDO) to degrade tryptophan and the enzyme GTP-cyclohydrolase I to form neopterin. High neopterin concentrations as well as an increased kynurenine to tryptophan ratio (Kyn/Trp) in the blood of cancer patients are predictive for a worse outcome. Inflammation-mediated tryptophan catabolism along the kynurenine pathway is related to fatigue and anemia as well as to depression and a decreased QoL in patients with solid tumors. In fact, enhanced tryptophan breakdown might greatly contribute to the development of anemia, fatigue, and depression in cancer patients. IDO activation and stimulation of the kynurenine pathway exert immune regulatory mechanisms, which may impair anti-tumor immune responses. In addition, tumor cells can degrade tryptophan to weaken immune responses directed against them. High IDO expression in the tumor tissue is associated with a poor prognosis of patients. The efficiency of IDO-inhibitors to inhibit cancer progression is currently tested in combination with established chemotherapies and with immune checkpoint inhibitors. Inflammation-mediated tryptophan catabolism and its possible influence on the development and persistence of anemia, fatigue, and depression in cancer patients are discussed.

Neopterin and biopterin levels and tryptophan degradation in patients with diabetes

“…Tryptophan metabolism is triggered by inflammation and/or degeneration in diabetes, causing increased Kyn metabolites 47 . Oxenkurg 25,26 has reported that, a high level of Kyn/Trp is associated with altered Trp levels in hemodialysis patients with diabetes.…”

COLEC12 regulates apoptosis of osteosarcoma through Toll‐like receptor 4–activated inflammation

“…Of the potential new targets, the environment of inflammation has received considerable attention and become an immunotherapy challenge for re-inducing an antitumoral response. [7][8][9] TNF-α and ILs are pro-inflammatory cytokines produced by lymphocytes and macrophages, which can induce apoptosis of tumor cells and are associated with the progression of several types of tumors, including OS. 10,11 In addition, TNF-α and ILs are transcriptionally controlled by NF-kB and C3 signaling 12,13 ; therefore, searching the upstream key factors to regulate the inflammatory response may be a vital step in the treatment of osteosarcoma.…”

Data Mining and System Pharmacology to Elucidate the Efficiency and Mechanism of Chinese Medicine in Treating Primary Liver Cancer

“…Incidence of PLC is closely related to choric virus infection and/or cirrhosis, which present tumor cells existing in an in ammatory microenvironment [50][51][52]. Interleukin-17 (IL-17) family produced by CD4+ T helper (Th) cells plays a vital role in orchestrating host immune responses [53].…”